[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ptprc-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"PTPRC Gene",4,[7,15,21,27],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT03538899","Autologous Gene Therapy for Artemis-Deficient SCID",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:11.042248Z","2026-05-05T02:43:27.477543Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT04083183","Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases",[11],"2026-08-26T02:18:40.612983Z","2026-05-05T02:43:27.430728Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT03670966","211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome",[11],"2026-08-26T02:17:52.450442Z","2026-07-05T05:32:16.772513Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT03128034","211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia",[11],"2026-08-26T02:17:30.961790Z","2026-05-05T02:43:27.480643Z"]